High-resistance inspiratory muscle strength training, or IMST, can help strengthen your breathing muscles. Practicing it for ...

Pulmonary hypertension is a condition where specialist input is essential, yet the day-to-day management of many patients takes place in local hospitals, usually in general respiratory clinics, far ...

Pulmonary hypertension (PH) is a progressive disease marked by pulmonary arterial remodeling and right ventricular dysfunction. The molecular mechanisms driving this remodeling, particularly ECM ...

Cardiovascular outcomes show increased complications for patients facing gastrointestinal procedures with elevated pulmonary pressure. A link to this article will be included in this email. SAN ...

The Scottish Medicines Consortium (SMC) has rejected the use of sotatercept for improving exercise capacity in adults with pulmonary arterial hypertension (PAH) in NHS Scotland. The regulator said the ...

Dear Dr. Roach: I am struggling with a decision process due to a lack of consensus among various physicians. I was fortunate back in January at 66 years of age to survive bilateral pulmonary emboli ...

Dr. Qanta Ahmed analyzes Trump's historic meeting with Saudi crown prince Dr. Qanta Ahmed, senior fellow at the Independent Women's Forum and Council on Foreign Relations member, analyzes the ...

Please provide your email address to receive an email when new articles are posted on . Advancements in treatment directed by risk stratification and the availability of novel targeted therapy provide ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 2 CADENCE study evaluating WINREVAIR™ ...

Merck received positive results from a Phase 2 trial evaluating a treatment for pulmonary hypertension. Merck on Tuesday said its drug, Winrevair, met the primary endpoint in a Phase 2 study in adults ...

WILLIAMSPORT, Pa. — November is Chronic Obstructive Pulmonary Disease or COPD Awareness Month. The American Lung Association says COPD affects more than 11 million adults and accounts for hundreds of ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the U.S.